Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.

Abstract:

:The proteasome inhibitor, bortezomib, is known to be effective in the therapy of various neoplasms. The objective of this study was the analysis of the ex vivo activity of bortezomib in paediatric acute lymphoblastic leukaemia (ALL), in comparison to paediatric acute myeloid leukaemia (AML). A total of 159 patients entered the study, including 106 ALL (including 86 precursor-B-cell ALL, and 20 T-cell ALL) and 53 AML children. The ex vivo sensitivity to bortezomib and 16 other drugs was studied by MTT assay. Paediatric AML samples were more resistant than paediatric ALL samples to most of the tested drugs, except for cytarabine and thioguanine. With respect to immunophenotype, ex vivo drug resistance in T-cell ALL (T-ALL) was higher for most of the drugs. No differences in drug resistance between T-ALL and common/pre-B-cell-ALL were found for daunorubicin, mitoxantrone and 6-thioguanine. Bortezomib was the only compound which was more active in T-ALL than in common/pre-B-ALL paediatric samples. In conclusion, bortezomib had good ex vivo activity in paediatric T-ALL samples.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Szczepanek J,Pogorzala M,Konatkowska B,Juraszewska E,Badowska W,Olejnik I,Kuzmicz M,Stanczak E,Malinowska I,Stefaniak J,Sobol G,Szczepanski T,Czyzewski K,Wysocki M,Styczynski J

subject

Has Abstract

pub_date

2010-06-01 00:00:00

pages

2119-24

issue

6

eissn

0250-7005

issn

1791-7530

pii

30/6/2119

journal_volume

30

pub_type

杂志文章
  • The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.

    abstract:BACKGROUND/AIM:Since androgens affect urothelial bladder cancer (UBC), we examined whether 5α-reductases (5-AR) have genomic alterations in UBC and whether 5α-reductase inhibitors (5-ARI) affect UBC. MATERIALS AND METHODS:The cBioPortal was used to analyze genomic alternations of 5-ARs in UBC cancer genomic datasets. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12152

    authors: Chen CC,Huang CP,Tsai YT,Hseih TF,Shyr CR

    更新日期:2017-12-01 00:00:00

  • Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantation.

    abstract::Milky spots (MS), peritoneal lymphoid tissues, expose the extracellular matrix (ECM) due to a defect of mesothelial cells on their surface, which may explain why peritoneal implantation of cancer cells preferentially takes place at MS. We recently reported that adenovirus vector-mediated intraperitoneal production of ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshimura M,Fujiwara H,Kubota T,Amaike H,Takashima K,Inada S,Atsuji K,Araki Y,Matsumoto K,Nakamura T,Yamagishi H

    更新日期:2005-11-01 00:00:00

  • Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma.

    abstract::Apoptotic cell death, in conjunction with mitosis, plays an important role in maintaining tissue homeostasis. Many cancer treatment modalities have been shown to induce apoptosis in sensitive cells. The purpose of this study was to determine the amount of apoptosis in-situ, the expression of apoptosis related genes p5...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pulkkinen JO,Klemi P,Martikainen P,Grénman R

    更新日期:1999-01-01 00:00:00

  • Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.

    abstract:BACKGROUND/AIM:The aim of the present study was to determine the efficacy of trabectedin combined with FOLFIRI (irinotecan, leucovorin and 5-fluorouracil) on a colorectal cancer (CRC) patient-derived orthotopic xenograft (iPDOX) mouse model. MATERIALS AND METHODS:A CRC tumor from a patient previously established in nu...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13860

    authors: Zhu G,Zhao M,Han Q,Tan Y,Sun YU,Bouvet M,Clary B,Singh SR,Ye J,Hoffman RM

    更新日期:2019-12-01 00:00:00

  • Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection.

    abstract:BACKGROUND:In order to develop a multi-marker RT-PCR, which as such may be more sensitive than a single marker assay for the detection of disseminated tumor cells, we evaluated six RT-PCR markers: cytokeratin 20 (CK20), carcinoembryonic antigen (CEA), guanylyl cyclase C (GCC), epidermal growth factor receptor (EGFR), m...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Vlems FA,Diepstra JH,Cornelissen IM,Ligtenberg MJ,Wobbes T,Punt CJ,van Krieken JH,Ruers TJ,van Muijen GN

    更新日期:2003-01-01 00:00:00

  • Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer.

    abstract:BACKGROUND:The different clinical evolution of breast cancer with similar pathological characteristics prompted the authors to investigate the prognostic significance of different biological markers. METHODS:Seventy-one primary breast carcinoma specimens obtained by mastectomy or quadrantectomy were examined for the d...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Midulla C,De Iorio P,Nagar C,Pisani T,Cenci M,Valli C,Nofroni I,Vecchione A

    更新日期:1999-09-01 00:00:00

  • Low renal toxicity of lipoplatin compared to cisplatin in animals.

    abstract::Cisplatin is one of the most widely used and effective chemotherapeutic agents for the treatment of several human malignancies. Although the effectiveness of cisplatin is high, its toxicities justify the demand for improved formulations of this drug. A liposomal formulation of cisplatin, Lipoplatin, was developed in o...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Devarajan P,Tarabishi R,Mishra J,Ma Q,Kourvetaris A,Vougiouka M,Boulikas T

    更新日期:2004-07-01 00:00:00

  • Cancer treatment of severely-III patients not eligible for chemotherapy.

    abstract:BACKGROUND:Despite having disseminated cancer, not all patients are eligible for palliative chemotherapy or targeted therapies. AIM:To study reasons for withholding palliative chemotherapy, to survey which alternatives were offered and to study survival outcomes. MATERIALS AND METHODS:Medical records of 346 patients ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Randén M,Runesdotter S,Strang P

    更新日期:2013-12-01 00:00:00

  • Cryotreatment against metastatic renal cell bone tumour reduced multiple lung metastases.

    abstract::Metastatic renal cell carcinoma (RCC) has a poor response to anticancer chemotherapy and radiotherapy. While immunotherapy and molecular targeted drugs have been used as first-line therapy for RCC metastasis, the response rate to these agents is low. We report the case of a patient with lung and bone metastases of RCC...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishida H,Shirai T,Hayashi K,Takeuchi A,Tanzawa Y,Mizokami A,Namiki M,Tsuchiya H

    更新日期:2011-09-01 00:00:00

  • Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis.

    abstract:BACKGROUND/AIM:We performed a systematic review and meta-analysis to investigate the safety of maintenance with olaparib after platinum-based chemotherapy in cancer patients. MATERIALS AND METHODS:Eligible studies included randomized controlled trials (RCTs) regarding the clinical role of olaparib maintenance therapy ...

    journal_title:Anticancer research

    pub_type: 杂志文章,meta分析

    doi:10.21873/anticanres.13989

    authors: Ricci AD,Rizzo A,Novelli M,Tavolari S,Palloni A,Tober N,Abbati F,Mollica V,DE Lorenzo S,Turchetti D,DI Marco M,Brandi G

    更新日期:2020-02-01 00:00:00

  • Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival.

    abstract::Overexpression of p53-protein appears to be a common event in primary breast cancer. It has been proposed that the presence of elevated levels of this protein may be an independent prognostic factor and may be important for the ability of a tumor to metastasize. This study was performed to evaluate the influence of im...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hanzal E,Gitsch G,Kohlberger P,Dadak C,Miechowiecka N,Breitenecker G

    更新日期:1992-11-01 00:00:00

  • The Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Advanced Gastric Cancer.

    abstract:AIM:We examined whether the perioperative systemic inflammation score (SIS), which describes systemic inflammation and/or malnutrition, affected the tumor recurrence and survival in advanced gastric cancer patients. PATIENTS AND METHODS:The study retrospectively analyzed 160 patients with stage II/III gastric cancer w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14095

    authors: Hara K,Aoyama T,Yamada T,Nakazono M,Nagasawa S,Shimoda Y,Kumazu Y,Numata M,Hayashi T,Tamagawa H,Shiozawa M,Morinaga S,Yukawa N,Rino Y,Masuda M,Ogata T,Oshima T

    更新日期:2020-03-01 00:00:00

  • Sirtuin 1 Activation Suppresses the Growth of T-lymphoblastic Leukemia Cells by Inhibiting NOTCH and NF-κB Pathways.

    abstract:BACKGROUND/AIM:The deacetylase sirtuin1 (SIRT1) inhibits tumor suppressor p53 and may promote tumorigenesis; however, SIRT1 effects on leukemia cells are controversial. The aim of this study was to clarify the activity of SIRT1 in leukemia cells. MATERIALS AND METHODS:The effects of SIRT1 inhibition or activation and ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14297

    authors: Okasha SM,Itoh M,Tohda S

    更新日期:2020-06-01 00:00:00

  • Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells.

    abstract::Ascaridol is the active principle of the American wormseed Chenopodium anthelminticum L. We isolated ascaridol from a commercial preparation of Chenopodium oil and analyzed its activity against different tumor cell lines in vitro (CCRF-CEM, HL60, MDA-MB-231). Multidrug-resistant (MDR) counterparts of these cell lines ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Efferth T,Olbrich A,Sauerbrey A,Ross DD,Gebhart E,Neugebauer M

    更新日期:2002-11-01 00:00:00

  • Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.

    abstract::Norcantharidin (NCTD) was purified from mylabris, the dried body of the Chinese blister beetle. NCTD has been shown to exhibit anticancer activities in many human cancer cell lines, but there are no reports to show whether it induces apoptosis of human gastric cancer cells. Therefore, in the present study, we investig...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11192

    authors: Zheng LC,Yang MD,Kuo CL,Lin CH,Fan MJ,Chou YC,Lu HF,Huang WW,Peng SF,Chung JG

    更新日期:2016-11-01 00:00:00

  • Molecular analysis of Streptococcus anginosus-derived SagA peptides.

    abstract:BACKGROUND:SagA1 and SagA2 molecules produced from beta-hemolytic Streptococcus anginosus subsp. anginosus are composed of a leader peptide and a propeptide, and their mature form has hemolytic activity as a well-known Streptococcal peptide toxin, streptolysin. The function of these SagA molecules is thought to be depe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawaguchi Y,Tabata A,Nagamune H,Ohkura K

    更新日期:2014-08-01 00:00:00

  • The incidence of breast cancer: analysis of the age dependence.

    abstract::The incidence of female breast cancer was studied as a function of age in 71 different populations throughout the world. Incidence data was normalized for differences in frequency of occurrence. Median normalized incidence increased exponentially from age 20 to 45. After age 45 the rate of incidence decreased, and we ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Dix D,Cohen P

    更新日期:1982-01-01 00:00:00

  • Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.

    abstract::Calcitriol (1,25-dihydroxyvitamin D3), the active form of vitamin D, promotes growth inhibition and differentiation in prostate cancer (PCa) cells. To unravel the molecular pathways of calcitriol actions, cDNA microarray analysis was used to identify novel calcitriol target genes including two that play key roles in t...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Moreno J,Krishnan AV,Peehl DM,Feldman D

    更新日期:2006-07-01 00:00:00

  • Factors Influencing Disease Progression in Patients with Head and Neck Melanoma.

    abstract:BACKGROUND:Histological parameters as well as the status of sentinel lymph node are known to be strong prognostic factors in patients with melanoma. PATIENTS AND METHODS:In this study, we retrospectively analyzed 1,384 patients who were diagnosed with head and neck melanoma between 1976 and 2010 regarding prognostic f...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11759

    authors: Uslu U,Schuler G,Breuninger H

    更新日期:2017-07-01 00:00:00

  • Re-evaluation of prognostic mitotic figure counting in breast cancer: results of a prospective clinical follow-up study.

    abstract::Some years ago we were able to confirm reports on the prognostic meaning of mitotic figure counting in breast cancer on a retrospective series of 104 breast cancer cases (Hum Pathol 26: 47-52, 1995). An independent influence of mitotic figure counting on prognosis could be proven in stage I and stage II tumors. Using ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Biesterfeld S,Reitmaier M

    更新日期:2001-01-01 00:00:00

  • Lymphokine-activated killer cell therapy combined with high-dose glucocorticoid showed clinical efficacy towards advanced lung carcinoma.

    abstract::We describe the case of a patient with terminal adenocarcinoma of the lung with no response to lymphokine-activated killer (LAK) cell therapy alone who distinctly responded clinically to a combination of high-dose glucocorticoids (GC) and LAK cell therapy, administered by chance. However, after decreasing the dose of ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kato M,Goto S,Soma G

    更新日期:2010-08-01 00:00:00

  • Pomegranate extract induces cell cycle arrest and alters cellular phenotype of human pancreatic cancer cells.

    abstract:BACKGROUND:Pomegranate extract (PE) is a standardized whole-fruit extract of pomegranate, a fruit with known anticancer properties. MATERIALS AND METHODS:PANC-1 and AsPC-1 human pancreatic cancer cells were used as in vitro models to test the effects of PE. RESULTS:PE treatment induced cell cycle arrest and inhibited...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nair V,Dai Z,Khan M,Ciolino HP

    更新日期:2011-09-01 00:00:00

  • Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells.

    abstract:BACKGROUND:The standard treatment of epithelial ovarian cancer is tumor debulking by surgery, followed by six cycles of chemotherapy consisting of cisplatinum and paclitaxel. However, this therapy protocol is not satisfactory, since about 50% of the treated patients eventually experience recurrence within a few years o...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Law KS,Chen HC,Liao SK

    更新日期:2007-03-01 00:00:00

  • Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.

    abstract::In lung cancer patients tumor markers are used for disease monitoring. The goal of this study was to improve diagnostic efficiency in the detection of tumor progression in lung cancer patients by using fuzzy logic modeling in combination with a tumor marker panel (Tumor M2-PK, CYFRA 21-1, CEA, NSE and SCC). Thirty-thr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Schneider J,Peltri G,Bitterlich N,Neu K,Velcovsky HG,Morr H,Katz N,Eigenbrodt E

    更新日期:2003-03-01 00:00:00

  • Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.

    abstract:AIM:The purpose of the present study was to identify variables associated with high risk of failure in patients with locally advanced squamous cell carcinoma of the oral cavity (SCC-OC). PATIENTS AND METHODS:This retrospective study included 191 patients with stage III-IVb SCC-OC treated with post-operative radiothera...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Noble AR,Greskovich JF,Han J,Reddy CA,Nwizu TI,Khan MF,Scharpf J,Adelstein DJ,Burkey BB,Koyfman SA

    更新日期:2016-02-01 00:00:00

  • Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.

    abstract::The effects of the antineoplastic compound, vinorelbine, on the permeability of the blood-brain barrier (BBB) to the complex Evans blue/albumin were studied. Vinorelbine, at a dose range from 5 to 10 mg/kg, was infused (4 ml/kg over 2 min) into the left carotid artery of anesthetised male Sprague-Dawley rats. BBB disr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mouchard-Delmas C,Gourdier B,Vistelle R,Wiczewski M

    更新日期:1995-11-01 00:00:00

  • Signal transduction pathway to low-dose radiation-induced apoptosis in peripheral PNET cells.

    abstract::We investigated the signal transduction pathway to low-dose radiation-induced apoptosis in vitro in the human peripheral primitive neuroectodermal tumor (pPNET) cell line with wild-type p53 established in our laboratory. Apoptosis was induced by 2Gy irradiation in an almost p53-dependent manner in this model except fo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Imai R,Akimoto T,Maebayashi K,Ishikawa H,Sakurai H,Saitoh J,Hasegawa M,Mitsuhashi N,Nakano T

    更新日期:2002-09-01 00:00:00

  • Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.

    abstract:BACKGROUND/AIM:Fluorescence-guided surgery (FGS) of cancer is an emerging technology. We have previously shown the importance of resecting both the tumor and the tumor microenvironment (TME) for curative FGS. We also previously developed a syngeneic model using the mouse lymphoma cell line EL-4, expressing red fluoresc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.10988

    authors: Hasegawa K,Suetsugu A,Nakamura M,Matsumoto T,Kunisada T,Shimizu M,Saji S,Moriwaki H,Bouvet M,Hoffman RM

    更新日期:2016-09-01 00:00:00

  • Tenascin in preinvasive lesions of the vulva and vulvar cancer.

    abstract:OBJECTIVE:Vulvar cancer is a rare malignancy, representing approximately 5% of all female genital tract cancers and 1% of all malignancies in women. The incidence of vulvar carcinoma in situ (VIN III) has nearly doubled from 1.1 to 2.1 per 100,000 women-years between 1973 and 1987. It is more frequent among older women...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Goepel C,Stoerer S,Koelbl H

    更新日期:2003-11-01 00:00:00

  • Elective lymph node dissection for malignant melanoma: the tumor burden of nodal disease.

    abstract::Many retrospective trials have demonstrated a survival benefit for elective lymph node dissection (ELND) in the treatment of clinical stage I malignant melanoma, but two randomized trials have found none. The relevant medical literature was reviewed with special attention devoted to the tumor burden of nodal disease. ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Evans RA

    更新日期:1995-03-01 00:00:00